# Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical Trial

> **NCT04714710** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Pr. Nicolas GIRERD** · enrollment: 36 (actual)

## Conditions studied

- Brain-dead Organ Donors

## Interventions

- **DRUG:** IV Potassium Canrenoate
- **DRUG:** IV Sodium Chloride 0.9 %

## Key facts

- **NCT ID:** NCT04714710
- **Lead sponsor:** Pr. Nicolas GIRERD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-08-26
- **Primary completion:** 2023-12-06
- **Final completion:** 2033-12-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04714710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04714710, "Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04714710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*